{"schema_version":"1","generated_at":"2026-11-17T21:38:29.484Z","data_as_of":"2026-11-09","url":"https://www.findmykol.com/kol/luca-arecco","json_url":"https://www.findmykol.com/kol/luca-arecco/profile.json","record_kind":"full","profile_kind":"research","person":{"slug":"luca-arecco","name":"Luca Arecco","credential":"MD","title":"Research Fellow, Jules Bordet Institute","specialty":"Medicine","therapeutic_area":"Breast","therapeutic_areas":["Breast","Oncology"],"institution":"Institut Jules Bordet (Brussels)","institution_url":"https://www.findmykol.com/institution/institut-jules-bordet-brussels","register":{"country":"BE"}},"identifiers":{"orcid":"0000-0002-3818-0364","openalex":"A5021765093"},"summary":"Luca Arecco is Research Fellow, Jules Bordet Institute at Institut Jules Bordet (Brussels). OpenAlex indexes 112 publications with 1,383 citations (h-index 23).","overview":{"text":"Luca Arecco is Research Fellow, Jules Bordet Institute at Institut Jules Bordet (Brussels). The public record shows 112 publications with 1,383 citations (h-index 23), centered on Breast Cancer Treatment Studies, BRCA gene mutations in cancer, Reproductive Biology and Fertility.","bullets":["Most recent indexed publication: 2026 · Journal of the National Cancer Institute","Top research focus: Breast Cancer Treatment Studies"],"generated_at":"2026-11-17"},"focus":{"indications":[{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Obesity","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Osteoporosis","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1}],"research_topics":["Breast Cancer Treatment Studies","BRCA gene mutations in cancer","Reproductive Biology and Fertility","Advanced Breast Cancer Therapies","HER2/EGFR in Cancer Research"]},"scholarship":{"works_count":112,"cited_by_count":1383,"h_index":23,"i10_index":31,"pubmed_count":20,"latest_activity_year":2026,"source":"works"},"trials":{"shown":0,"withheld":0,"rows":[],"source":"trials"},"payments":{"note":"Not attributed. This person has no U.S. clinical registration (NPI) on file, so industry payments cannot be reliably tied to them."},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":20,"years":{"first":2021,"last":2026},"societies":["AACR","ASCO","ESHRE Annual Meeting","ESMO"],"shown":3,"withheld":17,"rows":[{"title":"Abstract 1063: Serum neuron-specific enolase (NSE) as a biomarker of central nervous system (CNS) metastases: Updated results from the BrainStorm program (Oncodistinct 006)","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-1063","source_url":"https://doi.org/10.1158/1538-7445.am2026-1063","status":"verified"},{"title":"Impact of BRCA pathogenic variants and novel targeted agents on ovarian reserve measured by anti-Müllerian hormone levels in young women with early breast cancer: A biomarker analysis of the PREFER study.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"presenting_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.526","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.526","status":"verified"},{"title":"Impact of germline BRCA pathogenic or likely pathogenic variants on fertility potential and reproductive outcomes in young women with breast cancer: A systematic review and meta-analysis.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"presenting_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.10606","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.10606","status":"verified"}],"source":"congress"},"publications":{"total":20,"shown":5,"withheld":15,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib.","year":2026,"journal":"Journal of the National Cancer Institute","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42599204/","status":"verified"},{"title":"The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.","year":2025,"journal":"Tumori","types":["Journal Article","Practice Guideline"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40947910/","status":"verified"},{"title":"Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship.","year":2025,"journal":"Therapeutic advances in medical oncology","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40979227/","status":"verified"},{"title":"Gonadotoxicity of immunotherapy and targeted agents in patients with cancer and impact on subsequent pregnancies.","year":2025,"journal":"Human reproduction (Oxford, England)","types":["Journal Article","Review","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40482082/","status":"verified"},{"title":"Response to Venkataraman and Mokbel.","year":2025,"journal":"Journal of the National Cancer Institute","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40341362/","status":"verified"}],"source":"publications"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"x","url":"https://x.com/lucarecco","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"social_posts":{"stored_total":6,"shown":3,"withheld":3,"rows":[{"platform":"x","post_id":"2060797070374564194","url":"https://x.com/lucarecco/status/2060797070374564194","handle":"lucarecco","posted_at_from_id":"2026-05-30T18:54:43.992Z","collected_at":"2026-11-05T21:33:50.004Z","sources":[{"hub":"asco26","society_slug":"asco","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-asco26-conference","https://kolpulse.com/kol-pulse-trial-profile-lidera"]}]},{"platform":"x","post_id":"2060794909875998874","url":"https://x.com/lucarecco/status/2060794909875998874","handle":"lucarecco","posted_at_from_id":"2026-05-30T18:46:08.889Z","collected_at":"2026-11-05T21:33:50.004Z","sources":[{"hub":"asco26","society_slug":"asco","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-asco26-conference"]}]},{"platform":"x","post_id":"2060791832322167207","url":"https://x.com/lucarecco/status/2060791832322167207","handle":"lucarecco","posted_at_from_id":"2026-05-30T18:33:55.143Z","collected_at":"2026-11-05T21:33:50.004Z","sources":[{"hub":"asco26","society_slug":"asco","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-asco26-conference","https://kolpulse.com/kol-pulse-trial-profile-optima"]}]}],"coverage":"Saved references from selected congress pages, joined through reviewed account identifiers. Not a complete X history or evidence of attendance. Post availability may change."},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD","source_url":"https://breastcancerinyoungwomen.org/luca-arecco/","status":"provisional","collected_at":"2026-11-09"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"ESMO Research Fellowship (2024)","source_url":"https://esmo.org/newsroom/esmo-society-updates/2024-esmo-fellowship-awardees-announced","status":"provisional","collected_at":"2026-11-09"}]},"secondary_affiliations":{"total":3,"shown":3,"rows":[{"value":"Medical Oncology resident, Clinical Oncology Unit, IRCCS Ospedale Policlinico San Martino, University of Genoa (Genoa, Italy)","source_url":"https://breastcancerinyoungwomen.org/luca-arecco/","status":"provisional","collected_at":"2026-11-09"},{"value":"Academic Trials Promoting Team, Institut Jules Bordet, with Hôpital Universitaire de Bruxelles (HUB)","source_url":"https://breastcancerinyoungwomen.org/luca-arecco/","status":"provisional","collected_at":"2026-11-09"},{"value":"Doctorate Student / Research Assistant, Laboratory of Clinical Cell Therapy, Jules Bordet Institute","source_url":"https://loop.frontiersin.org/people/1062561/overview","status":"provisional","collected_at":"2026-11-09"}]}},"similar":[{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Eric Winer","slug":"eric-winer","institution":"Yale School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/eric-winer","json_url":"https://www.findmykol.com/kol/eric-winer/profile.json"},{"name":"Norman Wolmark","slug":"norman-wolmark","institution":"University of Pittsburgh","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/norman-wolmark","json_url":"https://www.findmykol.com/kol/norman-wolmark/profile.json"},{"name":"Hope Rugo","slug":"hope-rugo","institution":"City of Hope","specialty":"Hematology","url":"https://www.findmykol.com/kol/hope-rugo","json_url":"https://www.findmykol.com/kol/hope-rugo/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":17,"publications":15,"social_posts":3}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-09"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-09"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-09"}},"methodology_url":"https://www.findmykol.com/about#methodology"}